New markers of neonatal neurology
Authors:
- Diego GazzoloDGDiego Gazzolo
- Raul AbellaRARaul Abella
- Emanuela MarinoniEMEmanuela Marinoni
- Romolo di IorioRIRomolo di Iorio
- Giovanni Li VoltiGiovanni Li Volti
- Fabio GalvanoFabio Galvano
- Alessandro FrigiolaAFAlessandro Frigiola
- Francesca TemporiniFTFrancesca Temporini
- Luca MorescoLMLuca Moresco
- Micaela ColivicchiMCMicaela Colivicchi
- Miriam SabatiniMSMiriam Sabatini
- Alberto RicottiARAlberto Ricotti
- 1 January 2009
- journal article
- review article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 22 (sup3) , 57-61
Abstract
Hypoxia-ischemia (H-I) constitutes the main phenomenon responsible for brain-blood barrier permeability modifications leading to cerebral vascular auto-regulation loss in newborns. Hypotension, cerebral ischemia, and reperfusion are the main events involved in vascular auto-regulation loss leading to cell death and tissue damage. Reperfusion could be critical since organ damage, particularly of the brain, may be amplified during this period. An exaggerated activation of vasoactive agents, of calcium mediated effects could be responsible for reperfusion injury (R-I), which, in turns, leads to cerebral hemorrhage and damage. These phenomena represent a common repertoire in newborns complicated by perinatal acute or chronic hypoxia treated by risky procedures such as mechanical ventilation, nitric oxide supplementation, brain cooling, and extracorporeal membrane oxygenation (ECMO). Despite accurate monitoring, the post-insult period is crucial, as clinical symptoms and standard monitoring parameters may be silent at a time when brain damage is already occurring and the therapeutic window for pharmacological intervention is limited. Therefore, the measurement of circulating biochemical markers of brain damage, such as vasoactive agents and nervous tissue peptides is eagerly awaited in clinical practice to detect high risk newborns. The present review is aimed at investigating the role of biochemical markers such as adrenomedullin, a vasoactive peptide; S100B, a calcium binding protein, activin A, a glycoprotein, in the cascade of events leading to I-R injury in newborns complicated by perinatal asphyxia.Keywords
This publication has 39 references indexed in Scilit:
- Birth stress increases adrenomedullin in the newbornActa Paediatrica, 2007
- Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growthOncogene, 2001
- Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991–94Acta Paediatrica, 2001
- Mechanisms of perinatal brain injurySeminars in Neonatology, 2000
- Increased Plasma Levels of Adrenomedullin in Patients with Systemic Inflammatory Response SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Hypoxia-induced adrenomedullin production in the kidneyKidney International, 1999
- The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987‐90Acta Paediatrica, 1996
- Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage.Proceedings of the National Academy of Sciences, 1995
- WHY DOES PERINATAL MORBIDITY INCREASEJournal of Perinatal Medicine, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993